BIO375H5 Lecture Notes - Lecture 2: Adalimumab, Biochip, Medical Device

82 views4 pages
24 May 2017
School
Department
Course
Professor

Document Summary

Medical biology commercialization office hour: thursday, 5 -6 pm. The business model should be integrated to sell the biomedical product. Today: how you can generally bring the biomedical product into the market. Buyers, suppliers, industry rivalry, regulation required to bring the products into the market, threats to new substitutes. Technology trend: the same product to the market in a diff period of time the results may not the same. The timing of selling the product or tech is crucial. You need to also know about the stock market for biotech (nasdaq: it is either rising or dropping) Monoclonal antibodies (mabs): what is the diff between polyclonal or monoclonal, not part of this course. It is based on the gene her2 (textbook pg. This may not be useful for all of the breast cancer patients. Same thing is applied to any other of the diseases. Example: arterio sclerosis drug a targets enzyme a while drug b targets enzyme b.